Filter posts

Navigating the Rare Disease World

The international orphan drug marketplace is expected to grow some 30 percent by 2014, fueled …

Rare Disease Day: Families and Advocacy Groups Drive Treatments for Rare Diseases

Today, we celebrate Rare Disease Day to recognize the path to treatments and cures is …

2013 BIO International Convention Program Highlights

I’m thrilled to be attending the upcoming 2013 BIO International Convention that is coming to …

Auto Injectors & Pen Injectors: Differentiating Products in Asia Pacific

Asia Pacific, with its mix of mature and emerging pharmaceutical markets and strong indigenous R&D …

What’s Behind the Rise in Executive Liability Insurance Prices?

What do gas, milk, bacon, electricity and now your Directors and Officers Liability Insurance coverage …

Delivering on the Promise of Personalized Medicine

As sequencing moves out of the lab and into the clinic, a host of players …

The Future of Biodefense: Will Public-Private Partnerships Continue?

Ten years ago, in the wake of the 2001 anthrax attacks, the U.S. government set …

Inter Partes Review – a Useful Tool for Overcoming Freedom-to-Operate Obstacles

By Eric K. Steffe, Eldora L. Ellison, Ph.D., Todd Spalding, and Deborah A. Sterling, Ph.D. …

Academics to be Featured at the 2013 BIO Alliance Pavilion

I think it safe to say that the U.S. biotechnology industry has its R&D roots …

SIPO Examiner Workshop: Biotech Patent Practices in the U.S., China and Japan

The biotechnology industry is an invention-intensive industry that relies heavily on the protection of intellectual …